Repository logo
 

Identification of cis -acting determinants mediating the unconventional secretion of tau

Published version
Peer-reviewed

Change log

Authors

Katsinelos, Taxiarchis 
McEwan, William A. 
Jahn, Thomas R. 
Nickel, Walter 

Abstract

Abstract: The deposition of tau aggregates throughout the brain is a pathological characteristic within a group of neurodegenerative diseases collectively termed tauopathies, which includes Alzheimer’s disease. While recent findings suggest the involvement of unconventional secretory pathways driving tau into the extracellular space and mediating the propagation of the disease-associated pathology, many of the mechanistic details governing this process remain elusive. In the current study, we provide an in-depth characterization of the unconventional secretory pathway of tau and identify novel molecular determinants that are required for this process. Here, using Drosophila models of tauopathy, we correlate the hyperphosphorylation and aggregation state of tau with the disease-related neurotoxicity. These newly established systems recapitulate all the previously identified hallmarks of tau secretion, including the contribution of tau hyperphosphorylation as well as the requirement for PI(4,5)P2 triggering the direct translocation of tau. Using a series of cellular assays, we demonstrate that both the sulfated proteoglycans on the cell surface and the correct orientation of the protein at the inner plasma membrane leaflet are critical determinants of this process. Finally, we identify two cysteine residues within the microtubule binding repeat domain as novel cis-elements that are important for both unconventional secretion and trans-cellular propagation of tau.

Description

Funder: UK Dementia Research Institute; doi: http://dx.doi.org/10.13039/501100017510


Funder: Chica and Heinz Schaller Foundation; doi: http://dx.doi.org/10.13039/501100012284

Keywords

Article, /631/80/2023, /631/378/1689/1283, /631/80/313/2376, article

Journal Title

Scientific Reports

Conference Name

Journal ISSN

2045-2322

Volume Title

11

Publisher

Nature Publishing Group UK
Sponsorship
Alzheimer Forschung Initiative (13806, 13806)
Deutsche Forschungsgemeinschaft (SFB/TRR 186, SFB/TRR 186)
Horizon 2020 Framework Programme (Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 116060 (IMPRiND), Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 116060 (IMPRiND))
Wellcome Trust (206248/Z/17/Z)